Preliminary results of a phase I study of sunitinib plus paclitaxel for first-line treatment of advanced breast cancer

被引：0
|
作者：
Kozloff, Mark [1 ]
Chuang, Ellen [2 ]
Roy, Jessica [3 ]
Starr, Alexander [1 ]
Gowland, Patricia A. [1 ]
Tarpey, Matthew J. [2 ]
Collier, Mary [4 ]
Verkh, Lev [4 ]
Kern, Kenneth [4 ]
Miller, Kathy [3 ]
机构：
[1] Ingalls Mem Hosp, Harvey, IL USA
[2] Cornell Univ, Weill Med Coll, New York, NY USA
[3] Indiana Univ Canc Ctr, Indianapolis, IN USA
[4] Pfizer Global Res & Dev, La Jolla, CA USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3591S / 3591S
页数：1
相关论文
共 50 条
  • [1] Preliminary results of a phase I study of sunitinib plus paclitaxel for first-line treatment of advanced breast cancer
    Kozloff, M.
    Chuang, E.
    Roy, J.
    Starr, A.
    Gowland, P. A.
    Tarpey, M. J.
    Collier, M.
    Verkh, L.
    Kern, K.
    Miller, K.
    EJC SUPPLEMENTS, 2007, 5 (04): : 216 - 216
  • [2] A phase I study of sunitinib plus paclitaxel for first-line treatment of advanced breast cancer: preliminary results.
    Kozloff, M. F.
    Chuang, E.
    Roy, J.
    Starr, A.
    Gowland, P. A.
    Tarpey, M. J.
    Coliler, M.
    Verk, L.
    Kern, K.
    Miller, K.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S273 - S273
  • [3] Carboplatin plus paclitaxel in the first-line treatment of advanced ovarian cancer: Preliminary results of a phase I study
    Lhomme, C
    Kerbrat, P
    Lejeune, C
    Guastalla, JP
    Fumoleau, P
    Goupil, A
    Heron, JF
    Cassin, MA
    Pruvot, I
    Soares, JA
    Chazard, M
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 48 - 54
  • [4] An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer
    Kozloff, M.
    Chuang, E.
    Starr, A.
    Gowland, P. A.
    Cataruozolo, P. E.
    Collier, M.
    Verkh, L.
    Huang, X.
    Kern, K. A.
    Miller, K.
    ANNALS OF ONCOLOGY, 2010, 21 (07) : 1436 - 1441
  • [5] Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial
    Robert, Nicholas J.
    Saleh, Mansoor N.
    Paul, Devchand
    Generali, Daniele
    Gressot, Laurent
    Copur, Mehmet S.
    Brufsky, Adam M.
    Minton, Susan E.
    Giguere, Jeffrey K.
    Smith, John W., II
    Richards, Paul D.
    Gernhardt, Diana
    Huang, Xin
    Liau, Katherine F.
    Kern, Kenneth A.
    Davis, John
    CLINICAL BREAST CANCER, 2011, 11 (02) : 82 - 92
  • [6] Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer
    Luck, HJ
    Thomssen, C
    duBois, A
    Lisboa, BW
    Untch, M
    Kuhnle, H
    Janicke, F
    Meerpohl, HG
    Lindner, C
    Kcnecny, G
    Hecker, D
    Diergarten, K
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S13 - S16
  • [7] Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: Preliminary results
    Belli, L
    LeChevalier, T
    Gottfried, M
    Adams, D
    Ruffle, P
    LeCesne, A
    Tete, L
    PellaeCosset, B
    SEMINARS IN ONCOLOGY, 1995, 22 (06) : 29 - 33
  • [8] Preliminary results of a randomized phase II study of paclitaxel and bevacizumab ± gemcitabine as first-line treatment for metastatic breast cancer
    Hoelzer, K. L.
    Brufsky, A.
    Hainsworth, J.
    Beck, J. T.
    Whorf, R.
    Keaton, M.
    Kroener, J.
    Krill-Jackson, E.
    Hu, S.
    Bromund, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: Preliminary results
    Hitt, R
    Hornedo, J
    Colomer, R
    Mendiola, C
    Brandariz, A
    Sevilla, E
    AlvarezVicent, J
    CortesFunes, H
    SEMINARS IN ONCOLOGY, 1995, 22 (06) : 50 - 54
  • [10] Gemcitabine plus paclitaxel as first-line chemotherapy for patients with advanced breast cancer
    Delfino, C
    Caccia, G
    Gonzáles, LR
    Mickiewicz, E
    Rodger, J
    Balbiani, L
    Morales, DF
    Comba, AZ
    Brosio, C
    ONCOLOGY, 2004, 66 (01) : 18 - 23
12345